alexa Abstract | A comparative study of efficacy and safety of conventional versus newer antidepressants in patients with depressive episode in a tertiary care hospital

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


To compare the efficacy and safety of newer antidepressants like Escitalopram and Desvenlafaxine versus conventional antidepressant like Imipramine in patients with Depressive episode. An open label, prospective, comparative study was conducted in the psychiatry outpatient department (OPD), Victoria hospital, from Nov 2011- May 2013. 90 newly diagnosed patients of depressive episode according to ICD-10 criteria were divided into three groups of 30 each receiving Imipramine (Group A), Escitalopram (Group B) and Desvenlafaxine (Group C) and followed up for 12 weeks. Efficacy measurement was reduction in MADRS, CGI-S and CGI-I scores. Safety assessment was by number, severity and dropouts due to adverse drug reactions and laboratory investigations. Data was analyzed using ANOVA and Chi square test. Response rate was 63% in Group B, 53% in Group A and 50% in Group C, but this difference was not statistically significant. Initial response was seen as early as 2 weeks in 63% in group B and 43% in group C but none in group A and showed statistical significance. No statistically significant difference was seen in CGI-S and CGI-I scores at the end of 12 weeks. 43 ADRs were noted in group A most of which were moderate in severity, 27 ADRs and 37 ADRs were noted in group B and C respectively, most of which were mild. 9 patients in group A and 4 patients each in group B and C dropped out before the completion of the study. Commonest reason for drop out in groups A and B were ADRs whereas in group C was lack of response. No statistically significant difference was noted in efficacy between the three drugs however, escitalopram and desvenlafaxine had faster onset of action and were better tolerated than imipramine.

To read the full article Peer-reviewed Article PDF image

Author(s): Divyashree M Jayanthi C R and Chandrashekar H


Antidepressants, Imipramine, Escitalopam, Desvenlafaxine, antidepressants

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version